Homeopathy 2009; 98(01): 11-16
DOI: 10.1016/j.homp.2008.11.008
Original Paper
Copyright © The Faculty of Homeopathy 2008

Evaluation of the quality of life after individualized homeopathic treatment for seasonal allergic rhinitis. A prospective, open, non-comparative study

Maria Goossens
1   Department of General Practice, Katholieke Universiteit Leuven, ACHG-KULeuven, Kapucijnenvoer 33, Blok J, bus 7001, 3000 Leuven, Belgium
,
Gert Laekeman
2   Pharmacology, Katholieke Universiteit Leuven, Belgium
,
Bert Aertgeerts
1   Department of General Practice, Katholieke Universiteit Leuven, ACHG-KULeuven, Kapucijnenvoer 33, Blok J, bus 7001, 3000 Leuven, Belgium
,
Frank Buntinx
1   Department of General Practice, Katholieke Universiteit Leuven, ACHG-KULeuven, Kapucijnenvoer 33, Blok J, bus 7001, 3000 Leuven, Belgium
3   Universiteit Maastricht, The Netherlands
,
The ARCH study group: Marc Dandois, Leon Scheepers, Jean-Louis Smout, Michel van Wassenhoven, Jo Linmans, Erwin Doeuvre › Author Affiliations

Subject Editor:
Further Information

Publication History

Received20 January 2008
revised15 October 2008

accepted18 November 2008

Publication Date:
20 December 2017 (online)

Background: Quality of life (QoL) is an important outcome measure in the treatment of seasonal allergic rhinitis (SAR), a condition for which homeopathy is frequently used.

Objective The assessment of the effect of homeopathic medical prescriptions with the Rhino-conjunctivitis Quality of Life Questionnaire (RQLQ) in the treatment of SAR.

Methods: A prospective, open, non-comparative study was conducted in Belgium. Patients aged between 14 and 68 years with SAR were treated by one of seven homeopathic physicians. Patients completed the RQLQ at baseline and again after three and four weeks of homeopathic treatment.

Results: Seventy-four patients were screened, of whom 46 met the study eligibility criteria (average age 36 years, 70% female). The mean RQLQ score at baseline was 3.40 (±.98). After three and four weeks of homeopathic treatment it had fallen to 1.97 (±1.32) (P = 0.0001), and 1.6 (±1.28) (P = 0.0001), respectively.

Conclusions: After homeopathic treatment, patients reported an alleviation of their symptoms of allergic rhinitis as reported in the RQLQ. A formal Randomized Clinical Trial (RCT) is indicated.

 
  • References

  • 1 Jones N.S., Carney A.S., Davis A. The prevalence of allergic rhinosinusitis: a review. J Laryngol Otol 1998 Nov; 112 (11) 1019-1030.
  • 2 Bellanti J.A., Wallerstedt D.B. Allergic rhinitis update: epidemiology and natural history. Allergy Asthma Proc 2000 Nov–Dec; 21 (06) 367-370.
  • 3 Kurowski M., Kuna P., Gorski P. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation. Allergy 2004 Mar; 59 (03) 280-288.
  • 4 Gupta R., Sheikh A., Strachan D.P., Anderson H.R. Time trends in allergic disorders in the UK. Thorax 2007 Jan; 62 (01) 91-96.
  • 5 Bousquet J., Van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 Nov; 108 (Suppl. 05) S147-S334.
  • 6 Van Cauwenberge P., Van Hoecke H. Management of allergic rhinitis. B-ENT 2005 (suppl. 1): 45-62 quiz 3–4.
  • 7 Passalacqua G., Bousquet P.J., Carlsen K.H. et al. ARIA update: I – Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol 2006 May; 117 (05) 1054-1062.
  • 8 Becker-Witt C., Ludtke R., Weisshuhn T.E., Willich S.N. Diagnoses and treatment in homeopathic medical practice. Forsch Komplementarmed Klass Naturheilkd 2004 Apr; 11 (02) 98-103.
  • 9 Witt C.M., Ludtke R., Baur R., Willich S.N. Homeopathic medical practice: long-term results of a cohort study with 3981 patients. BMC Public Health 2005; 5: 115.
  • 10 Bartholomeeusen S., Truyers C., Buntinx F. Ziekten in de huisartpraktijk in Vlaanderen. Intego; 2004. pp 15–28.
  • 11 McCarney R.W., Linde K., Lasserson T.J. Homeopathy for chronic asthma. Cochrane Database Syst Rev 2004; 1 (01) CD000353.
  • 12 O'Mathuna D.P., Horgan J.M. Seasonal allergic rhinitis study results of questionable relevance to homeopathy. Ann Pharmacother 2005 Apr; 39 (04) 736-738.
  • 13 Juniper E.F., Thompson A.K., Ferrie P.J., Roberts J.N. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999 Aug; 104 2 Pt 1 364-369.
  • 14 Juniper E.F., Guyatt G.H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991 Jan; 21 (01) 77-83.
  • 15 Juniper E.F., Thompson A.K., Roberts J.N. Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36. Allergy 2002 Mar; 57 (03) 201-206.
  • 16 Juniper E.F., Guyatt G.H., Griffith L.E., Ferrie P.J. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996 Oct; 98 (04) 843-845.
  • 17 Spence D.S., Thompson E.A., Barron S.J. Homeopathic treatment for chronic disease: a 6-year, university-hospital outpatient observational study. J Altern Complement Med 2005 Oct; 11 (05) 793-798.